搜尋結果
Cheng, C. M. ,
Hong, H. J. ,
Liu, J. C. ,
Shih, N. L. ,
Juan, S. H. ,
Loh, S. H. ,
Chan, P. ,
Chen, J. J. &
Cheng, T-H. ,
5月 1 2003 ,
於: Molecular Pharmacology. 63 ,
5 ,
p. 1002-1011 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Extracellular Signal-Regulated MAP Kinases
100%
Endothelin-1
99%
Reactive Oxygen Species
73%
Fibroblasts
68%
Gene Expression
55%
Lee, M. H. ,
Chan, P. ,
Chiou, H. J. &
Cheung, W. K. ,
1月 1996 ,
於: Clinical Imaging. 20 ,
1 ,
p. 26-30 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Infected Aneurysm
100%
Salmonella
74%
Diagnostic Imaging
73%
Aorta
61%
Tomography
48%
Chen, T. H. ,
Kao, Y. C. ,
Chen, B. C. ,
Chen, C. H. ,
Chan, P. &
Lee, H. M. ,
7月 17 2006 ,
於: European Journal of Pharmacology. 541 ,
3 ,
p. 138-146 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Mitogen-Activated Protein Kinase Phosphatases
100%
Dual Specificity Phosphatase 1
98%
RAW 264.7 Cells
84%
Dipyridamole
79%
Cyclooxygenase 2
68%
Chen, T. H. ,
Chang, C. F. ,
Yu, S. C. ,
Wang, J. C. ,
Chen, C. H. ,
Chan, P. &
Lee, H. M. ,
6月 24 2009 ,
於: European Journal of Pharmacology. 613 ,
1-3 ,
p. 10-18 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
cobaltous chloride
100%
Dipyridamole
85%
Osteopontin
82%
Mitogen-Activated Protein Kinase Phosphatases
53%
Dual Specificity Phosphatase 1
52%
Hsieh, M. H. ,
Tai, C. T. ,
Chiang, C. E. ,
Tsai, C. F. ,
Chen, Y. J. ,
Chan, P. ,
Kuo, Y. C. ,
Lee, S. H. ,
Ueng, K. C. &
Chen, S. A. ,
10月 2004 ,
於: Journal of Interventional Cardiac Electrophysiology. 11 ,
2 ,
p. 97-103 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Wolff-Parkinson-White Syndrome
100%
Coronary Sinus
87%
Atrial Fibrillation
65%
Atrioventricular Nodal Reentry Tachycardia
21%
Incidence
17%
Chan, P. ,
Tomlinson, B. ,
Huang, T. Y. ,
Ko, J. T. ,
Lin, T. S. &
Lee, Y. S. ,
3月 1997 ,
於: Journal of Clinical Pharmacology. 37 ,
3 ,
p. 253-257 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Metolazone
100%
Lisinopril
78%
Losartan
67%
Angiotensin-Converting Enzyme Inhibitors
55%
Cough
53%
Yang, H. Y. ,
Cheng, J. J. ,
Cheng, T-H. ,
Liu, J. C. ,
Chan, P. &
Cheng, J. T. ,
9月 2003 ,
於: Acta Cardiologica Sinica. 19 ,
3 ,
p. 143-148 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Pheochromocytoma
100%
Ascorbic Acid
89%
Cultured Cells
75%
Antioxidants
66%
Down-Regulation
62%
Kao, P. F. ,
Lee, W. S. ,
Liu, J. C. ,
Chan, P. ,
Tsai, J. C. ,
Hsu, Y. H. ,
Chang, W. Y. ,
Cheng, T-H. &
Liao, S. S. ,
2003 ,
於: Pharmacology. 69 ,
1 ,
p. 1-6 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Ascorbic Acid
100%
Astrocytes
92%
Superoxide Dismutase
92%
Down-Regulation
70%
Gene Expression
60%
Liu, J. C. ,
Chow, J. M. ,
Tsai, M. F. ,
Hsieh, M. H. ,
Chen, Y. J. &
Chan, P. ,
2000 ,
於: Acta Cardiologica Sinica. 16 ,
4 ,
p. 209-216 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Ascorbic Acid
100%
Superoxide Dismutase
92%
Smooth Muscle Myocytes
88%
Down-Regulation
70%
Gene Expression
60%
Wang, Y. ,
Liu, J. ,
Chen, X. ,
Sun, H. ,
Peng, S. ,
Kuang, Y. ,
Pi, J. ,
Zhuang, T. ,
Zhang, L. ,
Yu, Z. ,
Tomlinson, B. ,
Chan, P. ,
Chen, Y. ,
Zhang, Y. &
Li, Y. ,
1月 1 2019 ,
於: Journal of Cellular and Molecular Medicine. 23 ,
1 ,
p. 476-486 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Acute Coronary Syndrome
100%
Interleukin-1
98%
Signal Transduction
77%
Macrophages
69%
Monocytes
54%
Liu, Z. M. ,
Hu, M. ,
Chan, P. &
Tomlinson, B. ,
5月 1 2015 ,
於: Expert Opinion on Investigational Drugs. 24 ,
5 ,
p. 611-621 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Investigational Drugs
100%
Peroxisome Proliferator-Activated Receptors
86%
Metabolic Diseases
74%
Drug Delivery Systems
70%
Dyslipidemias
43%
Chan, P. ,
Tomlinson, B. ,
Lee, C. B. &
Lee, Y. S. ,
1996 ,
於: Journal of Clinical Pharmacology. 36 ,
5 ,
p. 422-427 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Squalene
100%
Pravastatin
89%
Hypercholesterolemia
67%
Placebos
46%
Elderly
45%
Chen, Y. C. ,
Tsai, J. C. ,
Liou, Y. M. &
Chan, P. ,
6月 1 2017 ,
於: European Journal of Cardiovascular Nursing. 16 ,
5 ,
p. 397-408 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Endurance Training
100%
Coronary Artery Disease
66%
Meta-Analysis
59%
Randomized Controlled Trials
53%
Exercise
51%
Chan, P. ,
Cheng, J. T. ,
Tsai, J. C. ,
Lien, G. S. ,
Chen, F. C. ,
Kao, P. F. ,
Liu, J. C. ,
Chen, Y. J. &
Hsieh, M. H. ,
8月 16 2002 ,
於: Neuroscience Letters. 328 ,
3 ,
p. 281-284 4 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Catechin
100%
Astrocytes
72%
Superoxide Dismutase
72%
Gene Expression
47%
Antioxidants
38%
Chen, Y. C. ,
Chen, S. A. ,
Chen, Y. J. ,
Tai, C. T. ,
Chan, P. &
Lin, C. I. ,
1月 12 2004 ,
於: European Journal of Pharmacology. 483 ,
2-3 ,
p. 215-222 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Pulmonary Veins
100%
Cardiac Myocytes
80%
Ethanol
73%
Atrial Fibrillation
38%
Action Potentials
26%
Tong, Y. C. ,
Wang, C. J. ,
Chan, P. &
Cheng, J. T. ,
5月 2000 ,
於: Urologia Internationalis. 64 ,
3 ,
p. 149-153 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
imidazole
100%
Angiotensin Type 1 Receptor
95%
Losartan
93%
Inbred SHR Rats
84%
Inbred WKY Rats
73%
Chen, Y. J. ,
Tsai, C. F. ,
Chiou, C. W. ,
Chan, P. &
Chen, S. A. ,
2001 ,
於: Pharmacology. 62 ,
4 ,
p. 213-217 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Strophanthidin
100%
Ventricular Tachycardia
62%
Arginine
54%
Nitric Oxide
48%
Guinea Pigs
17%
Tsai, M. F. ,
Chen, T. H. ,
Liu, J. C. ,
Chen, Y. J. ,
Hsieh, M. H. &
Chan, P. ,
2001 ,
於: Acta Cardiologica Sinica. 17 ,
1 ,
p. 3-8 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
tetramethylpyrazine
100%
Vascular Smooth Muscle
64%
Smooth Muscle Myocytes
58%
Calcium
45%
Blood Pressure
41%
Wong, K. L. ,
Chan, P. ,
Huang, W. C. ,
Yang, T. L. ,
Liu, I. M. ,
Lai, T-I. ,
Tsai, C. C. &
Cheng, J. T. ,
10月 2003 ,
於: Clinical and Experimental Pharmacology and Physiology. 30 ,
10 ,
p. 793-798 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
tetramethylpyrazine
100%
Potassium Channels
75%
Smooth Muscle Myocytes
58%
Calcium
45%
KATP Channels
18%
Chan, P. ,
Niu, C. S. ,
Tomlinson, B. ,
Hong, C. T. ,
Chen, J. P. ,
Hong, C. Y. ,
Tsai, S. K. &
Cheng, J. T. ,
1月 1 1997 ,
於: Pharmacology. 55 ,
5 ,
p. 252-258 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
trilinolein
100%
Ventricular Pressure
54%
Superoxide Dismutase
47%
Hypoxia
40%
Perfusion
38%
Liu, J. C. ,
Chan, P. ,
Cheng, J. T. ,
Chen, J. P. ,
Lee, S. T. ,
Chang N.-, C. &
Tomlinson, B. ,
1998 ,
於: Acta Cardiologica Sinica. 14 ,
2 ,
p. 52-57 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
trilinolein
100%
Cardiac Myocytes
47%
Superoxide Dismutase
47%
Hypoxia
40%
Perfusion
38%
Chiu, W. T. ,
Chan, P. ,
Liao, S. S. ,
Liou, J. R. &
Cheng, J. T. ,
7月 2 1999 ,
於: Neuroscience Letters. 269 ,
1 ,
p. 17-20 4 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
trilinolein
100%
Astrocytes
47%
Superoxide Dismutase
47%
Gene Expression
30%
Brain
25%
Wang, C. H. ,
Chung, M. H. ,
Chan, P. ,
Tsai, J. C. &
Chen, F. C. ,
2014 ,
於: Geriatric Nursing. 35 ,
3 ,
p. 212-218 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Endurance Training
100%
Metabolic Syndrome
73%
Interleukin-6
61%
Exercise
51%
HDL Cholesterol
17%
Chiou, C. S. ,
Lin, J-W. ,
Kao, P. F. ,
Liu, J-C. ,
Cheng, T-H. &
Chan, P. ,
8月 2008 ,
於: Clinical and Experimental Pharmacology and Physiology. 35 ,
8 ,
p. 938-943 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Hesperidin
100%
Endothelin-1
71%
Human Umbilical Vein Endothelial Cells
70%
Nitric Oxide
33%
Extracellular Signal-Regulated MAP Kinases
17%
Chan, P. ,
Liu, J. C. ,
Tong, Y. C. ,
Chen, Y. J. ,
Wang, C. C. ,
Tomlinson, B. &
Cheng, J. T. ,
3月 1999 ,
於: Pharmacology. 58 ,
3 ,
p. 132-139 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Losartan
100%
Sexual Behavior
80%
Libido
65%
Inbred SHR Rats
54%
Ejaculation
42%
Hsieh, M. H. ,
Chen, Y. J. ,
Chan, P. &
Chen, S. A. ,
6月 2003 ,
於: Acta Cardiologica Sinica. 19 ,
2 ,
p. 95-100 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Cisapride
100%
Magnesium Sulfate
89%
Lidocaine
71%
Canidae
59%
Heart
44%
Chen, Y. J. ,
Chen, S. A. ,
Chen, Y. C. ,
Yeh, H. I. ,
Chan, P. ,
Chang, M. S. &
Lin, C. I. ,
12月 4 2001 ,
於: Circulation. 104 ,
23 ,
p. 2849-2854 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Pulmonary Veins
100%
Cardiac Myocytes
80%
Atrial Fibrillation
77%
Dogs
31%
Electrophysiology
16%
Yang, H. Y. ,
Kao, P. F. ,
Chen, T. H. ,
Tomlinson, B. ,
Ko, W. C. &
Chan, P. ,
3月 2007 ,
於: Journal of Clinical Pharmacology. 47 ,
3 ,
p. 397-403 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Valsartan
100%
Angiotensin II Type 1 Receptor Blockers
98%
Superoxide Dismutase
67%
Reactive Oxygen Species
41%
Placebos
36%
Chen, Y. C. ,
Chen, S. A. ,
Chen, Y. J. ,
Chang, M. S. ,
Chan, P. &
Lin, C. I. ,
1月 16 2002 ,
於: Journal of the American College of Cardiology. 39 ,
2 ,
p. 366-372 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Pulmonary Veins
100%
Thyroid Hormones
87%
Hyperthyroidism
82%
Cardiac Myocytes
80%
Action Potentials
17%
Chan, P. ,
Chang, J. J. ,
Chen, F. C. ,
Wu, M. S. ,
Tomlinson, B. &
Cheng, J. T. ,
2000 ,
於: Clinical and Experimental Pharmacology and Physiology. 27 ,
12 ,
p. 1002-1006 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
trilinolein
100%
Superoxide Dismutase
47%
Smooth Muscle Myocytes
45%
Antioxidants
37%
Messenger RNA
29%
Hsieh, M. H. ,
Chan, P. ,
Sue, Y. M. ,
Liu, J. C. ,
Liang, T. H. ,
Huang, T. Y. ,
Tomlinson, B. ,
Chow, M. S. S. ,
Kao, P. F. &
Chen, Y. J. ,
11月 2003 ,
於: Clinical Therapeutics. 25 ,
11 ,
p. 2797-2808 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
stevioside
100%
Essential Hypertension
60%
Placebos
39%
Blood Pressure
36%
Left Ventricular Hypertrophy
13%
Wu, K. C. ,
Wong, K. L. ,
Wang, M. L. ,
Shiao, L. R. ,
Leong, I. L. ,
Gong, C. L. ,
Cheng, K. S. ,
Chan, P. &
Leung, Y. M. ,
1月 1 2018 ,
於: Journal of Physiological Sciences. 68 ,
1 ,
p. 33-41 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Eicosapentaenoic Acid
100%
Cerebral Cortex
75%
Endothelial Cells
26%
cyclopiazonic acid
13%
Fish Oils
11%
Pi, J. ,
Liu, J. ,
Zhuang, T. ,
Zhang, L. ,
Sun, H. ,
Chen, X. ,
Zhao, Q. ,
Kuang, Y. ,
Peng, S. ,
Zhou, X. ,
Yu, Z. ,
Tao, T. ,
Tomlinson, B. ,
Chan, P. ,
Tian, Y. ,
Fan, H. ,
Liu, Z. ,
Zheng, X. ,
Morrisey, E. &
Zhang, Y. ,
2018 ,
於: Theranostics. 8 ,
6 ,
p. 1511-1526 16 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Endothelial Cells
100%
Cell Movement
63%
Cell Proliferation
50%
Actins
32%
MicroRNAs
32%
Liu, J. ,
Zhuang, T. ,
Pi, J. ,
Chen, X. ,
Zhang, Q. ,
Li, Y. ,
Wang, H. ,
Shen, Y. ,
Tomlinson, B. ,
Chan, P. ,
Yu, Z. ,
Cheng, Y. ,
Zheng, X. ,
Reilly, M. ,
Morrisey, E. ,
Zhang, L. ,
Liu, Z. &
Zhang, Y. ,
8月 20 2019 ,
於: Circulation. 140 ,
8 ,
p. 665-680 16 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Forkhead Transcription Factors
100%
Endothelin-1
81%
Transforming Growth Factors
79%
Signal Transduction
59%
Endothelial Cells
55%
Zhuang, T. ,
Liu, J. ,
Chen, X. ,
Zhang, L. ,
Pi, J. ,
Sun, H. ,
Li, L. ,
Bauer, R. ,
Wang, H. ,
Yu, Z. ,
Zhang, Q. ,
Tomlinson, B. ,
Chan, P. ,
Zheng, X. ,
Morrisey, E. ,
Liu, Z. ,
Reilly, M. &
Zhang, Y. ,
8月 30 2019 ,
於: Circulation Research. 125 ,
6 ,
p. 590-605 16 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Kruppel-Like Transcription Factors
100%
Inflammasomes
81%
Atherosclerosis
54%
Simvastatin
32%
Inflammation
31%
Li, H. ,
Wang, Y. ,
Liu, J. ,
Chen, X. ,
Duan, Y. ,
Wang, X. ,
Shen, Y. ,
Kuang, Y. ,
Zhuang, T. ,
Tomlinson, B. ,
Chan, P. ,
Yu, Z. ,
Cheng, Y. ,
Zhang, L. ,
Liu, Z. ,
Zhang, Y. ,
Zhao, Z. ,
Zhang, Q. &
Liu, J. ,
1月 1 2021 ,
於: Theranostics. 11 ,
4 ,
p. 1609-1625 17 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Simvastatin
100%
Endothelial Cells
62%
Pressure
11%
Heart Failure
8%
Ventricular Remodeling
7%
Ma, Y. B. ,
Chan, P. ,
Zhang, Y. ,
Tomlinson, B. &
Liu, Z. ,
5月 24 2019 ,
於: Expert Opinion on Pharmacotherapy. 20 ,
8 ,
p. 917-928 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Ezetimibe
100%
Atorvastatin
87%
Hypercholesterolemia
72%
Safety
42%
Lipids
33%
Chong, N. S. ,
Yin, W. H. ,
Chan, P. ,
Cheng, M. C. ,
Ko, H. L. ,
Jeng, S. C. &
Lee, J. J. S. ,
2000 ,
於: Chinese Medical Journal (Taipei). 63 ,
11 ,
p. 816-821 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Cardiac Catheterization
100%
Radiation
72%
Cardiologists
59%
Catheterization
51%
Radiation Dosimeters
28%
Zhang, L. ,
Chan, P. ,
Liu, Z. M. ,
Gasbarri, M. ,
Lin, M. T. ,
Chen, C. W. ,
Hou, A. L. ,
Chang, C. Y. ,
Chen, Y. C. ,
Chen, Y. S. ,
Chan, W. P. &
Leung, T-K. ,
2017 ,
於: Acupuncture and Electro-Therapeutics Research. 41 ,
3-4 ,
p. 207-224 18 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Musculoskeletal Manipulations
100%
Acupuncture Points
94%
Reflex
69%
Ear
67%
Urinary Bladder
61%
Tomlinson, B. ,
Hu, M. ,
Zhang, Y. ,
Chan, P. &
Liu, Z. M. ,
2月 1 2017 ,
於: Expert Opinion on Drug Metabolism and Toxicology. 13 ,
2 ,
p. 211-223 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Empagliflozin
100%
empagliflozin
82%
Symporters
72%
Sodium-Glucose Transporter 2 Inhibitors
57%
Pharmacokinetics
40%
Tomlinson, B. ,
Hu, M. ,
Zhang, Y. ,
Chan, P. &
Liu, Z. M. ,
11月 2 2017 ,
於: Expert Opinion on Biological Therapy. 17 ,
11 ,
p. 1447-1461 15 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
evolocumab
100%
Low-Density Lipoprotein Cholesterol
94%
Antilipemic Agent
61%
Hypercholesterolemia
59%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
57%
Chiou, A. F. ,
Wang, H. L. ,
Chan, P. ,
Ding, Y. A. ,
Hsu, K. L. &
Kao, H. L. ,
9月 2009 ,
於: The journal of nursing research : JNR. 17 ,
3 ,
p. 221-230 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Behavior Therapy
100%
Taiwan
82%
Coronary Artery Disease
68%
Self Efficacy
28%
Type A Personality
15%
Chan, P. ,
Chen, J. H. ,
Lee, M. H. &
Deng, J. F. ,
1994 ,
於: Clinical Toxicology. 32 ,
2 ,
p. 147-155 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Hemodynamic
100%
Methamphetamine
90%
Creatinine
81%
Cooling
59%
Intensive Care Units
56%
Cao, H. ,
Ye, L. ,
Chan, P. ,
Fan, H. &
Liu, Z. ,
2月 7 2015 ,
於: Medicine (United States). 94 ,
7 ,
p. e530 研究成果: 雜誌貢獻 › 文章 › 同行評審
Coronary Aneurysm
100%
Ventricular Premature Complexes
86%
Pulmonary Artery
65%
Fistula
64%
Aneurysm
63%
Kuang, Y. S. ,
Li, X. ,
Chen, X. ,
Sun, H. ,
Tomlinson, B. ,
Chan, P. ,
Zheng, L. ,
Pi, J. ,
Peng, S. ,
Wu, H. ,
Ding, X. ,
Qian, D. ,
Shen, Y. ,
Yu, Z. ,
Fan, L. ,
Chen, M. ,
Fan, H. ,
Liu, Z. &
Zhang, Y. ,
9月 30 2016 ,
於: Scientific Reports. 6 , 34268.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Independent Living
100%
oxidized low density lipoprotein
97%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
94%
Elderly
65%
Lipids
19%
Hemangioma
100%
Heart Failure
67%
Cavernous Hemangioma
60%
Arteriovenous Fistula
53%
Skin
50%
Zhang, L. ,
Liang, Y. ,
Pan, H. ,
Liu, X. ,
Lin, Y. ,
Liu, Z. &
Chan, P. ,
7月 26 2012 ,
於: International Journal of Cardiology. 158 ,
3 ,
p. 438-441 4 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審